|
Re: Kadcyla/TDM1 CELEBRATION @ Genentech:)
I'm also very excited about the approval...now waiting for Health Canada. And good to know I wasn't the only one that didn't like the new name! But thanks for the explanation Chrisy, that does help to explain it.
I've been part of the EMILIA trial in Toronto, and have just received my 42nd infusion...WOW! And FYI, the Toronto Star (newspaper) is publishing a story about Antibody-Drug conjugates, including TDM-1 (I don't think it'll ever be Kadcyla for me) likely on Sat March 16. I was interviewed yesterday for this story, so it might include a one-line quote from me 
__________________
diagnosed April, 2007, age 36 - stage IV, mets to liver; ER+ (slightly), PR-, HER2+
MRM April 26, 2007
started chemo May 25, 2007 - Taxotere and Herceptin
finished chemo Oct 2007, continue on Herceptin for life, also on Tamoxifen
MRI in Jan 2008 shows no evidence of cancer in liver - NED!!
recurrence in left axilla nodes April 2010
now highly ER+, still HER2+
oophorectomy July 2010
start TDM1 (Emilia) trial Sept 2010
it's working!! can still palpate small node in axilla, but remain NED everywhere else
|